Suppr超能文献

小鼠实验性肺炎球菌感染:庆大霉素、奈替米星和妥布霉素的体外杀菌活性与体内效果的相关性

Experimental pneumococcus infection in mice: correlation of bactericidal activity in vitro with the effect in vivo for gentamicin, netilmicin and tobramycin.

作者信息

Frimodt-Møller N, Thomsen V F

出版信息

Acta Pathol Microbiol Immunol Scand B. 1987 Jun;95(3):153-8. doi: 10.1111/j.1699-0463.1987.tb03105.x.

Abstract

An experimental model in mice, incorporating the intraperitoneal inoculation of a Streptococcus pneumoniae type 3, was used to evaluate the effect in vivo after single-dose administration of the three aminoglycosides, gentamicin, tobramycin and netilmicin, and to correlate this effect with their in vitro activity against the pathogen, in particular the bactericidal rate. The minimal inhibitory concentrations (MIC's), which were equal to the minimal bactericidal concentrations (MBC's), were 12.5 micrograms/ml for netilmicin, and 25 micrograms/ml for the two other aminoglycosides, respectively. All three antibiotics showed excellent bactericidal activities even at concentrations 1/4 times the MIC's, but the bactericidal rate was clearly lower for tobramycin than for the two other aminoglycosides. The effect in vivo measured as the 50% effective dose (ED50) closely reflected the relative bactericidal activities of the drugs. Of the pharmacokinetic parameters investigated on dosages equal to the ED50's for the three drugs, the best to correlate with the bactericidal rates in vitro were the peak serum concentrations.

摘要

采用在小鼠体内腹腔接种3型肺炎链球菌的实验模型,评估单次给药庆大霉素、妥布霉素和奈替米星这三种氨基糖苷类药物后的体内效果,并将该效果与其对病原体的体外活性,特别是杀菌率进行关联。奈替米星的最低抑菌浓度(MIC)与最低杀菌浓度(MBC)相等,均为12.5微克/毫升,另外两种氨基糖苷类药物的MIC和MBC均为25微克/毫升。即使在浓度为MIC的1/4时,这三种抗生素均表现出优异的杀菌活性,但妥布霉素的杀菌率明显低于另外两种氨基糖苷类药物。以50%有效剂量(ED50)衡量的体内效果密切反映了药物的相对杀菌活性。在研究的与三种药物的ED50剂量相当的药代动力学参数中,与体外杀菌率相关性最好的是血清峰浓度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验